Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

186 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients.
de Bree R, Kuik DJ, Quak JJ, Roos JC, van den Brekel MW, Castelijns JA, van Wagtendonk FW, Greuter H, Snow GB, van Dongen GA. de Bree R, et al. Among authors: van den brekel mw, van wagtendonk fw, van dongen ga. Eur J Nucl Med. 1998 Nov;25(11):1562-5. doi: 10.1007/s002590050336. Eur J Nucl Med. 1998. PMID: 9799354 Clinical Trial.
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.
Colnot DR, Ossenkoppele GJ, Roos JC, Quak JJ, de Bree R, Börjesson PK, Huijgens PC, Snow GB, van Dongen GA. Colnot DR, et al. Among authors: van dongen ga. Clin Cancer Res. 2002 Nov;8(11):3401-6. Clin Cancer Res. 2002. PMID: 12429627 Clinical Trial.
186 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page